Biotech - Press Releases

Date	Title	Company
06-Jan-2023	Portfolio company Twelve Bio to be acquired alongside $85 million financing of Ensoma co-led by Arix to create best-in-class engineered cell therapy platform	Arix Bioscience plc
06-Jan-2023	New AI editing tool to speed up editing manuscripts	Cactus Communications
06-Jan-2023	Sartorius Collaborates with RoosterBio to Advance Downstream Purification Processes for the Manufacture of Exosomes	Sartorius
06-Jan-2023	Synaffix Enters License Agreement with Amgen to Build Next Generation ADCs	Synaffix B.V.
06-Jan-2023	Genoscience Pharma announces launch of phase 2b clinical trial of ezurpimtrostat to treat hepatocarcinoma in combination with an immune checkpoint inhibitor and an antiangiogenic agent	Andrew Lloyd Associates
06-Jan-2023	HighTide Therapeutics Raises $107 Million in Series C/C+ Financing to Advance Innovative Pipeline and Business Collaborations	HighTide Therapeutics Inc.
05-Jan-2023	BioVersys Extends its Series C Round to CHF 32.6 Million with Investment from the AMR Action Fund	BioVersys
05-Jan-2023	Adcendo ApS Announces License Agreement with Duality Biologics on Next-generation ADC Platform	Adcendo ApS
05-Jan-2023	iOnctura provides development update on first-in-class semi-allosteric PI3Kδ inhibitor program	iOnctura
05-Jan-2023	Transgene Announces Financial Calendar for 2023	Transgene
05-Jan-2023	STEMart Introduces API Impurity Identification Services for Medical Devices	STEMart
05-Jan-2023	CD BioSciences Introduces Label-Free Live Cell Imaging Services for Bio-Research	CD BioSciences
05-Jan-2023	CD BioSciences Introduces Various Solutions for Autophagic Cell Death Studies	CD BioSciences
04-Jan-2023	Infex’s novel AMR drug candidate MET-X receives FDA QIDP designation	Infex Therapeutics
04-Jan-2023	CD Bioparticles Announces Magnetofection Reagents for Gene Expression	CD Bioparticles
04-Jan-2023	CD Bioparticles Introduces Hydrophobic Interaction Chromatography Resins for Purification of Macromolecules	CD Bioparticles
04-Jan-2023	Creative Diagnostics Expands Its Monoclonal Antibodies Offering to Customers	Creative Diagnostics
04-Jan-2023	Creative Diagnostics Introduces New Hemagglutination Inhibition Assay Services	Creative Diagnostics
03-Jan-2023	Molecure Appoints Dr. Samson Fung, Chief Medical Officer to its Management Board as it Continues to Focus on Successfully Progressing its Expanded Clinical Portfolio	Molecure
03-Jan-2023	Evaxion receives approval from FDA to proceed with the clinical Phase 2b study for EVX-01	Evaxion Biotech